Aflibercept in Age-Related Macular Degeneration: Evaluating Its Role as a Primary Therapeutic Option
Eye - United Kingdom
doi 10.1038/eye.2017.81
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2017
Authors
Publisher
Springer Science and Business Media LLC